Study of emraclidine in healthy older adults
This study tests how the drug emraclidine moves through the body in healthy older adults. It helps researchers understand how the drug is processed and whether it is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are generally in good health with no major medical conditions.
- You have no known allergies to medications or foods.
- You have not had cancer (except certain skin cancers that were removed).
- Your body mass index (BMI) is between 18 and 32.
- You weigh more than 45 kg (about 99 pounds).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
This trial tests a new investigational drug, BMS-986446, given as a single dose to healthy volunteers and multiple doses to people with early Alzheimer's disease. It aims to understand how the drug moves in the body, its safety, and whether it triggers an immune response, which could help guide future treatment for Alzheimer's.
This is a Phase 1 study testing a new medicine called LY4178256. It will check how the drug is processed by the body and its safety in healthy volunteers. The results help doctors understand how to dose the drug in future studies.
This trial tests an experimental oral drug (emraclidine) to see if it helps symptoms of schizophrenia and how it moves through the body. It looks at two groups of participants: those with stable symptoms and those having an acute flare-up.
This trial is testing a new intravenous medicine (ME3241) for safety and how the body handles it. It's for healthy adults, so researchers can see how the drug works before testing it in people with the target condition.
This early-phase study tests a new experimental drug (M5542) in healthy volunteers to see how safe it is and how the body processes a single dose. If you are in good health and meet simple weight and medical history criteria, you may be able to join.
Hear when a new Healthy Volunteer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.